A paid diagnostic for qualified decision-makers who control meaningful intellectual property, cultural assets, production slates, archives, exhibitions, or founder-led ventures and need a credible path toward buyers, funders, sponsors, distributors, institutions, licensees, partners, or revenue.
Many projects have creative, cultural, or technical value but lack the structure required for market adoption. A film may be finished without a distribution pathway. An archive may be important but not institution-ready. A founder may have a product without the partner or investor narrative needed to scale.
The diagnostic exists to decide what should happen next before larger strategic, advisory, representation, sponsor, or institutional work begins.
Asset and opportunity assessment
Rights and ownership issue scan
Commercialization bottleneck diagnosis
Market, sponsor, partner, institution, or licensee pathway map
Materials-readiness scorecard
Missing-documentation list
Revenue-pathway assessment
30/60/90-day movement plan
One film, archive, exhibition, catalog, rights package, founder-led product, or defined IP asset.
One primary market objective, up to two stakeholder interviews, focused research, and a 2-3 week timeline.
Typical range: $7,500-$12,500.
Museums, foundations, estates, nonprofits, cultural institutions, or archive projects with multiple stakeholders.
One major program, exhibition, archive, or related asset cluster; up to five interviews; 3-5 week timeline.
Typical range: $25,000-$45,000.
Production slates, multi-asset catalogs, founder-led companies, family offices, institutions, or enterprise partners.
Portfolio prioritization, deeper market review, stakeholder mapping, revenue logic, and a 4-8 week timeline.
Custom scope, typically $45,000+.
No. A brief fit review may determine whether there is a reason to proceed, but strategic diagnosis, document review, market mapping, and recommendations belong inside a paid diagnostic.
No. Introductions are protected and occur only when the asset, rights, role, scope, and engagement terms are clear.
No. The diagnostic evaluates the asset, market pathway, readiness, and next decisions. Representation, outreach, sponsorship, or partner work may be considered only after the diagnostic or a separately scoped agreement.
A qualified prospect controls a meaningful asset, has decision-maker access, can identify a budget source, has a real commercialization problem, and is prepared to begin with paid professional advisory work if there is fit.
A Greene Group designs and supports credible market pathways. The firm does not guarantee financing, investment, sponsorship, distribution, licensing, sales, acquisition, audience results, or institutional acceptance.
The fit review determines whether a paid diagnostic may be appropriate. Please be prepared to identify asset control, decision authority, rights status, budget source, urgency, documentation, and readiness to begin a paid diagnostic.